Home » Biotechnology » Page 3

Tag

Biotechnology

Articles and news on UK and European growth companies operating in the biotechnology sector who are leveraging scientific advancements to innovate in sectors such as healthcare, agriculture, industrial processes, and environmental sustainability.

News

PolyTherics closes £2.15 million funding round

Technology investor Imperial Innovations has led a £2.15 million funding round for one its portfolio businesses biotechnology company PolyTherics.

News

Phico Therapeutics completes £1 million fundraising

Cambridge-based Phico Therapeutics has completed a £1 million fundraising round to help develop products that treat E. coli bacteria.

News

AstraZeneca and Heptares collaborate on drug development

AstraZeneca and Heptares Therapeutics have entered a four-year collaboration focused on the development of new drugs targeting proteins.

News

Private placing raises £25 million for Oxford Nanopore

Biotech developer Oxford Nanopore Technologies has raised £25 million in a latest financing round.

News

Viropro acquires biotech production facility

US-based biopharmaceutical company Viropro has acquired a Cambridge biotech facility in a deal worth $21 million (£13 million).

News

Mercia launches new biotech company

Seed investor The Mercia Fund has spun out a new venture, the Native Antigen Company (NAC), from existing portfolio company PsiOxus Therapeutics.

News

Oxford biotech spin-out raises £1.55 million

Crysalin, a spin-out from the University of Oxford's biochemistry department, has secured equity finance of £1.55 million.

News

Biotech start-ups starved of cash

Most of the UK's biotech start-ups receive no external funding, and the problem is particularly acute outside the South East, finds research.

News

Oxford Nanopore raises £17.4 million

New and existing investors have backed nanotechnology business Oxford Nanopore with an investment of £17.4 million.

News

Curzon Park leads Q Chip investment 

Biotech company Q Chip has received £1 million in a funding round led by cleantech venture investor Curzon Park Capital.

News

Source BioScience on the rebound

Healthcare and pharmaceutical services provider Source BioScience is mooting acquisitions after turning a £181,000 interim loss into £62,000 pre-tax profits.

News

German biotech sector booming

Germany's biotech sector has continued its strong run in 2008.

Recommended Content